Transaction Details

Footnotes

These shares sold pursuant to a 10b5-1 plan dated December 9, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $47.08 to $47.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $48.08 to $49.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $49.12 to $49.745, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | These shares are held by the Craig F. Courtemanche and Hillary Courtemanche Family Trust dated as of November 1, 2012. | These shares are held by the Courtemanche 2021 Irrevocable Trust UA DTD 6/10/2021. | These shares are held by The Courtemanche 2016 Irrevocable Trust. | The shares subject to the option vested in 60 equal monthly installments beginning on the one month anniversary of February 5, 2016, subject to continued service through each applicable vesting date.